Literature DB >> 11887937

Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.

D C Márquez1, J Lee, T Lin, R J Pietras.   

Abstract

Activation of estrogen receptor-alpha (ERalpha) by growth factors in the absence of estrogen is a well-documented phenomenon. To study further this process of ligand-independent receptor activation, COS-7 cells without ER were transfected with both ER and epidermal growth factor receptor (EGFR). In the absence of estrogen, epidermal growth factor (EGF) stimulated rapid tyrosine phosphorylation of ER in transfected COS-7 cells. Similarly, in MCF-7 breast cancer cells that have natural expression of ER and EGFR, EGF promoted acute phosphorylation of serine and tyrosine residues in ER, and a direct interaction between ER and EGFR after treatment with EGF was found. In confirmation of a direct interaction between ER and EGFR, activation of affinity-purified EGFR tyrosine kinase in vitro stimulated the phosphorylation of recombinant ER. The cross-communication between EGFR and ER appears to promote significant stimulation of cell proliferation and a reduction in the apoptotic loss of those cells that express both receptor signaling pathways. However, COS-7 cells transfected with both ER and EGFR show minimal stimulation of classical estrogen response element (ERE)-dependent transcriptional activity after stimulation by EGF ligand. This suggests that the proliferative and antiapoptotic activity of EGF-induced ER activation may be dissociated from ERE-dependent transcriptional activity of the ER.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11887937     DOI: 10.1385/ENDO:16:2:073

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  63 in total

Review 1.  Oestrogen receptors - an overview.

Authors:  E Enmark; J A Gustafsson
Journal:  J Intern Med       Date:  1999-08       Impact factor: 8.989

Review 2.  Molecular targets for breast cancer therapy and prevention.

Authors:  J Bange; E Zwick; A Ullrich
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

Review 3.  The caveolae membrane system.

Authors:  R G Anderson
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells.

Authors:  L Klein-Hitpass; M Schorpp; U Wagner; G U Ryffel
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

5.  Reduction of caveolin and caveolae in oncogenically transformed cells.

Authors:  A J Koleske; D Baltimore; M P Lisanti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.

Authors:  P T Ram; T Kiefer; M Silverman; Y Song; G M Brown; S M Hill
Journal:  Mol Cell Endocrinol       Date:  1998-06-25       Impact factor: 4.102

7.  The unliganded estrogen receptor (ER) transduces growth factor signals.

Authors:  C J Newton; R Buric; T Trapp; S Brockmeier; U Pagotto; G K Stalla
Journal:  J Steroid Biochem Mol Biol       Date:  1994-04       Impact factor: 4.292

8.  Overproduction of full-length and truncated human estrogen receptors in Escherichia coli.

Authors:  H Ahrens; T J Schuh; B L Rainish; J D Furlow; J Gorski; G C Mueller
Journal:  Receptor       Date:  1992

9.  Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum.

Authors:  W V Welshons; L H Grady; K S Engler; B M Judy
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

10.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

View more
  21 in total

1.  Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β.

Authors:  Hexiao Tang; Yongde Liao; Guang Chen; Liqiang Xu; Chao Zhang; Sheng Ju; Sheng Zhou
Journal:  Med Oncol       Date:  2012-03-17       Impact factor: 3.064

Review 2.  Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

Authors:  Viroj Boonyaratanakornkit; Nalo Hamilton; Diana C Márquez-Garbán; Prangwan Pateetin; Eileen M McGowan; Richard J Pietras
Journal:  Mol Cell Endocrinol       Date:  2017-11-14       Impact factor: 4.102

Review 3.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

Review 4.  Proteins of multiple classes may participate in nongenomic steroid actions.

Authors:  Cheryl S Watson; Bahiru Gametchu
Journal:  Exp Biol Med (Maywood)       Date:  2003-12

Review 5.  Role of oestrogen receptors in bladder cancer development.

Authors:  Iawen Hsu; Spencer Vitkus; Jun Da; Shuyuan Yeh
Journal:  Nat Rev Urol       Date:  2013-04-16       Impact factor: 14.432

6.  Application of computational approaches to study signalling networks of nuclear and Tyrosine kinase receptors.

Authors:  Mouna Choura; Ahmed Rebaï
Journal:  Biol Direct       Date:  2010-10-11       Impact factor: 4.540

7.  Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors.

Authors:  Rita Yusuf; Krystyna Frenkel
Journal:  Cancer Cell Int       Date:  2010-09-01       Impact factor: 5.722

Review 8.  Cellular targets of estrogen signaling in regeneration of inner ear sensory epithelia.

Authors:  Jennifer S McCullar; Elizabeth C Oesterle
Journal:  Hear Res       Date:  2009-02-06       Impact factor: 3.208

Review 9.  Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.

Authors:  Grazia Arpino; Lisa Wiechmann; C Kent Osborne; Rachel Schiff
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

10.  Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival.

Authors:  K Einarsdóttir; H Darabi; K Czene; Y Li; Y L Low; Y Q Li; C Bonnard; S Wedrén; E T Liu; P Hall; J Liu; K Humphreys
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.